Vnitr Lek 2004, 50(Supplement 1):S94-S97

[Idiopathic intestinal inflammations--contemporary therapeutic approaches].

V Zboril: Interní gastroenterologická klinika Lékarské fakulty MU a FN Brno.

Klíčová slova: Humans; Inflammatory Bowel Diseases, therapy,

Current pharmacotherapy of idiopathic intestinal inflammations can benefit from standard (conventional) therapies based on results of controlled studies, non-standard (unconventional) therapies based on pilot and uncontrolled studies, or can be a subject of clinical experiments. Clinical experimental area is a way to a progress in traditional treatment methods. Currently it includes a group of new drugs (immunosuppressives tacrolimus mycophenolate, thalidomide, biologic therapy, probiotics, neuroinflammation blockers), new treatment techniques (cytaphereses, sequential immunosuppression, immunosuppression with high doses), and finally new indications (chemoprophylaxis).